In DP as well as in KTR, these vaccine-dependent differences largely vanished (with the exception of IgA-ab against the Spike protein) and reached uniformly excellent results when COVID-19 pre-exposed patients were also vaccinated (Table S1B). The gene discussed is CD79A; the disease is COVID-19.